TABLE 3.
GO | Description | Count | % | Log10 (P) | Log10 (q) |
C0023893 | Liver cirhosis, experimental | 20 | 31.00 | –14.00 | –10.00 |
C0034069 | Pulmonary fibrosis | 7 | 11.00 | –8.70 | –5.10 |
C0021368 | Inflammation | 7 | 11.00 | –7.70 | –4.30 |
C0020538 | Hypertensive disease | 9 | 14.00 | –7.00 | –3.90 |
C0006663 | Calcinosis | 5 | 7.80 | –6.90 | –3.80 |
C0004096 | Asthma | 6 | 9.40 | −660 | –3.60 |
C0003873 | Rheumatoid arthritis | 7 | 11.00 | –6.40 | –3.40 |
C0011853 | Diabetes mellitus, experimental | 6 | 9.40 | –6.40 | –3.40 |
C0022658 | Kidney diseases | 6 | 9.40 | –6.20 | –3.30 |
C0020517 | Hypersensitivity | 5 | 7.80 | –6.20 | –3.30 |
C0027626 | Neoplasm invasiveness | 6 | 9.40 | –5.70 | –2.80 |
C0018824 | Heart valve disease | 4 | 6.20 | –5.60 | –2.80 |
C0017661 | IGA glomerulonephritis | 4 | 6.20 | –5.60 | –2.70 |
C0023895 | Liver diseases | 5 | 7.80 | –5.50 | –2.70 |
C0032285 | Pneumonia | 5 | 7.80 | –5.40 | –2.70 |
C0003862 | Arthralgia | 5 | 7.80 | –5.40 | –2.60 |
C0151744 | Myocardial ischemia | 6 | 9.40 | –5.20 | –2.50 |
C0007621 | Neoplastic cell transformation | 5 | 7.80 | –4.90 | –2.20 |
C0016663 | Pathological fracture | 3 | 4.70 | –4.70 | –2.00 |
C0162820 | Dermatitis, allergic contact | 4 | 6.20 | –4.60 | –1.90 |